308 related articles for article (PubMed ID: 32664894)
1. Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient.
Shingu Y; Nakata T; Sawai S; Tanaka H; Asai O; Tamagaki K; Nakatani K
BMC Nephrol; 2020 Jul; 21(1):275. PubMed ID: 32664894
[TBL] [Abstract][Full Text] [Related]
2. Resolution of epoetin-induced pure red cell aplasia 2 years later, successful re-challenge with continuous erythropoiesis receptor stimulator.
Lim SK; Bee PC; Keng TC; Chong YB
Clin Nephrol; 2013 Sep; 80(3):227-30. PubMed ID: 23298519
[TBL] [Abstract][Full Text] [Related]
3. Successful Treatment of Antibody-mediated Pure Red Cell Aplasia Induced by Continuous Erythropoietin Receptor Activator with Prednisolone.
Okahashi N; Kubo M; Hoshino E; Uchihara M; Amano I; Tanaka H
Intern Med; 2022 Jul; 61(14):2209-2213. PubMed ID: 34980800
[TBL] [Abstract][Full Text] [Related]
4. Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin.
Casadevall N
Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii37-41. PubMed ID: 14608000
[TBL] [Abstract][Full Text] [Related]
5. Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-α when the anti-erythropoietin antibody titer declines spontaneously.
Lee H; Yang J; Kim H; Kwon JW; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Kim S
J Korean Med Sci; 2010 Nov; 25(11):1676-9. PubMed ID: 21060762
[TBL] [Abstract][Full Text] [Related]
6. Pure red cell aplasia secondary to epoetin alpha responding to Darbepoetin alpha in a patient on peritoneal dialysis.
Asari A; Gokal R
J Am Soc Nephrol; 2004 Aug; 15(8):2204-7. PubMed ID: 15284306
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional immunosurveillance study of anti-EPO antibody levels in CRF patients receiving epoetin alfa in 5 Ontario Renal Centers.
Wu G; Wadgymar A; Wong G; Ting R; Nathoo B; Mendelssohn D; Pandeya S; Sapir D; Tam P
Am J Kidney Dis; 2004 Aug; 44(2):264-9. PubMed ID: 15264184
[TBL] [Abstract][Full Text] [Related]
8. Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient.
Mattison P; Upadhyay K; Wilcox JE; Moudgil A; Silverstein DM
Pediatr Nephrol; 2010 May; 25(5):971-6. PubMed ID: 20091055
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.
Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P;
J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241
[TBL] [Abstract][Full Text] [Related]
10. [Possible complications of erythropoietin therapy in patients with chronic renal failure].
Pljesa S
Med Pregl; 2004; 57(5-6):254-7. PubMed ID: 15503795
[TBL] [Abstract][Full Text] [Related]
11. Anti-epoetin-antibody-induced anemia in a child with chronic renal failure.
Jöbsis JJ; Fijnvandraat K; Stapel SO; Bouts AH
Pediatr Nephrol; 2010 May; 25(5):993-4. PubMed ID: 20165889
[No Abstract] [Full Text] [Related]
12. Pure red-cell aplasia induced by anti-erythropoietin antibodies in peritoneal dialysis.
Coronel F; García-Mena M; Martínez R
Clin Nephrol; 2004 Feb; 61(2):155-8. PubMed ID: 14989637
[TBL] [Abstract][Full Text] [Related]
13. Pure red cell aplasia and anti-erythropoietin antibodies in patients on hemodialysis: a report of two cases and a literature review.
Lacreta G; Bucharles SGE; Sevignani G; Riella MC; Nascimento MMD
J Bras Nefrol; 2019; 41(1):145-151. PubMed ID: 30160771
[TBL] [Abstract][Full Text] [Related]
14. [Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].
Miyazaki T; Obana T; Takasaki H; Tanaka M; Yamaji S; Fujimaki K; Fujita H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2007 May; 48(5):391-6. PubMed ID: 17571584
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
[TBL] [Abstract][Full Text] [Related]
16. [Early onset of anti- erythropoietin antibody-mediated pure red cell aplasia after commencement of subcutaneous administration of epoetin-β].
Tanaka A; Tsukada J; Morimoto H; Katsuragi T; Nakanishi T; Watanabe S; Hirase N; Motomura S
Rinsho Ketsueki; 2012 Jan; 53(1):110-2. PubMed ID: 22374534
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agent.
Jacob A; Sandhu K; Nicholas J; Jones H; Odum J; Rylance P; Carmichael P; Jackson M; Handa S; Macwhannell A; Basu S; Wahid F; Casadevall N; Mufti G; Macdougall I
Nephrol Dial Transplant; 2006 Oct; 21(10):2963-5. PubMed ID: 16861239
[No Abstract] [Full Text] [Related]
18. Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone.
Aoki K; Ono Y; Tabata S; Matsushita A; Ishikawa T
Int J Hematol; 2013 Feb; 97(2):272-4. PubMed ID: 23355260
[TBL] [Abstract][Full Text] [Related]
19. Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS).
Macdougall IC; Casadevall N; Locatelli F; Combe C; London GM; Di Paolo S; Kribben A; Fliser D; Messner H; McNeil J; Stevens P; Santoro A; De Francisco AL; Percheson P; Potamianou A; Foucher A; Fife D; Mérit V; Vercammen E;
Nephrol Dial Transplant; 2015 Mar; 30(3):451-60. PubMed ID: 25239637
[TBL] [Abstract][Full Text] [Related]
20. Antibody-mediated acquired pure red cell aplasia (PRCA) after treatment with darbepoetin.
Howman R; Kulkarni H
Nephrol Dial Transplant; 2007 May; 22(5):1462-4. PubMed ID: 17314208
[No Abstract] [Full Text] [Related]
[Next] [New Search]
